13F HOLDINGS REPORT
Camber Capital Management LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001654954-25-001508
Total Value
$4.3M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 2,500,000 | $1.5M | 33.89% |
| 2 | MEDTRONIC PLC | MDT | 2,750,000 | $219,670 | 5.08% |
| 3 | VIATRIS INC | VTRS | 15,000,000 | $186,750 | 4.32% |
| 4 | ZIMMER BIOMET HOLDINGS INC | ZBH | 1,605,000 | $169,536 | 3.92% |
| 5 | GSK PLC | GLAXF | 5,000,000 | $169,100 | 3.91% |
| 6 | HUMANA INC | HUM | 650,000 | $164,912 | 3.81% |
| 7 | PTC THERAPEUTICS INC | PTCT | 3,200,000 | $144,448 | 3.34% |
| 8 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1,150,000 | $141,623 | 3.28% |
| 9 | BAXTER INTL INC | 071813109 | 4,625,000 | $134,865 | 3.12% |
| 10 | CVS HEALTH CORP | CVS | 3,000,000 | $134,670 | 3.11% |
| 11 | PFIZER INC | PFE | 5,000,000 | $132,650 | 3.07% |
| 12 | PFIZER INC | PFE | 5,000,000 | $132,650 | 3.07% |
| 13 | SAREPTA THERAPEUTICS INC | SRPT | 1,000,000 | $121,590 | 2.81% |
| 14 | ASCENDIS PHARMA A/S | ASND | 800,000 | $110,136 | 2.55% |
| 15 | GLOBUS MED INC | GMED | 1,225,000 | $101,320 | 2.34% |
| 16 | GSK PLC | GLAXF | 2,500,000 | $84,550 | 1.96% |
| 17 | BROOKDALE SR LIVING INC | 112463104 | 13,935,000 | $70,093 | 1.62% |
| 18 | CONCENTRA GROUP HOLDINGS PAR | CON | 3,500,000 | $69,230 | 1.60% |
| 19 | QIAGEN NV | QGEN | 1,500,000 | $66,795 | 1.54% |
| 20 | DENALI THERAPEUTICS INC | DNLI | 2,250,000 | $45,855 | 1.06% |
| 21 | EVOLENT HEALTH INC | EVH | 4,000,000 | $45,000 | 1.04% |
| 22 | ALKERMES PLC | ALKS | 1,500,000 | $43,140 | 1.00% |
| 23 | MYRIAD GENETICS INC | MYGN | 3,100,000 | $42,501 | 0.98% |
| 24 | MEDPACE HLDGS INC | MEDP | 125,000 | $41,529 | 0.96% |
| 25 | THE CIGNA GROUP | 125523100 | 150,000 | $41,421 | 0.96% |
| 26 | ZIMVIE INC | 98888T107 | 2,725,000 | $38,014 | 0.88% |
| 27 | BIOMARIN PHARMACEUTICAL INC | BMRN | 450,000 | $29,579 | 0.68% |
| 28 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 441,000 | $23,880 | 0.55% |
| 29 | IONIS PHARMACEUTICALS INC | IONS | 625,000 | $21,850 | 0.51% |
| 30 | HERBALIFE LTD | HLF | 3,000,000 | $20,070 | 0.46% |
| 31 | INOGEN INC | INGN | 2,000,000 | $18,340 | 0.42% |
| 32 | BROOKDALE SR LIVING INC | 112463302 | 250,000 | $17,248 | 0.40% |
| 33 | ANAPTYSBIO INC | ANABV | 1,250,000 | $16,550 | 0.38% |
| 34 | ORASURE TECHNOLOGIES INC | OSUR | 4,250,000 | $15,343 | 0.35% |
| 35 | 10X GENOMICS INC | TXG | 1,000,000 | $14,360 | 0.33% |
| 36 | MERUS N V | N5749R100 | 250,000 | $10,513 | 0.24% |
| 37 | THERAVANCE BIOPHARMA INC | TBPH | 1,000,000 | $9,410 | 0.22% |
| 38 | STRUCTURE THERAPEUTICS INC | GPCR | 300,000 | $8,136 | 0.19% |
| 39 | GENMAB A/S | GNMSF | 50,000 | $1,044 | 0.02% |